Mereo BioPharma Group (HAM:MAH0) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Mereo BioPharma Group Days Payable?

Mereo BioPharma Group's average Accounts Payable for the three months ended in Dec. 2023 was €2.19 Mil. Mereo BioPharma Group's Cost of Goods Sold for the three months ended in Dec. 2023 was €-0.48 Mil.

The historical rank and industry rank for Mereo BioPharma Group's Days Payable or its related term are showing as below:

HAM:MAH0' s Days Payable Range Over the Past 10 Years
Min: 18.67 Med: 55.85 Max: 413.92
Current: 389.86

During the past 9 years, Mereo BioPharma Group's highest Days Payable was 413.92. The lowest was 18.67. And the median was 55.85.

HAM:MAH0's Days Payable is ranked better than
71.57% of 721 companies
in the Biotechnology industry
Industry Median: 148.78 vs HAM:MAH0: 389.86

Mereo BioPharma Group's Days Payable stayed the same from Dec. 2021 (0.00) to Dec. 2023 (0.00). stayed the same

Mereo BioPharma Group Days Payable Historical Data

The historical data trend for Mereo BioPharma Group's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mereo BioPharma Group Days Payable Chart

Mereo BioPharma Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

53.53

421.22

Mereo BioPharma Group Quarterly Data
	Jun15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial												-	-	-	88.09	-

Competitive Comparison of Mereo BioPharma Group's Days Payable

For the Biotechnology subindustry, Mereo BioPharma Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mereo BioPharma Group's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mereo BioPharma Group's Days Payable distribution charts can be found below:

* The bar in red indicates where Mereo BioPharma Group's Days Payable falls into.

Mereo BioPharma Group Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Mereo BioPharma Group's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (3.296	+	2.151)	/	2 )	/	2.36	*	365
=	2.7235					/	2.36	*	365
=	421.22

Mereo BioPharma Group's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (2.224	+	2.151)	/	2 )	/	-0.48	*	365 / 4
=	2.1875					/	-0.48	*	365 / 4
=	N/A

Mereo BioPharma Group Days Payable Related Terms

Thank you for viewing the detailed overview of Mereo BioPharma Group's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Mereo BioPharma Group (HAM:MAH0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mereo BioPharma Group PLC (HAM:MAH0) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

MREO:USA 0A9G:UK MAH0:Germany MAH0:Germany

Address

One Cavendish Place, 4th Floor, London, GBR, W1G 0QF

Website

https://www.mereobiopharma.com

Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its oncology product candidate is etigilimab, for patients with solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod.

Mereo BioPharma Group (HAM:MAH0) Headlines

No Headlines